Page last updated: 2024-09-05

symmetric dimethylarginine and Liver Cirrhosis

symmetric dimethylarginine has been researched along with Liver Cirrhosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Drescher, FT; Rauwerda, JA; Richir, MC; Siroen, MP; Teerlink, T; van Leeuwen, PA; Wiest, R; Zorger, N	1

Other Studies

1 other study(ies) available for symmetric dimethylarginine and Liver Cirrhosis

Article	Year
Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients. World journal of gastroenterology, 2008, Dec-21, Volume: 14, Issue:47 Topics: Adult; Aged; Aged, 80 and over; Arginine; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; Portasystemic Shunt, Transjugular Intrahepatic	2008

Article

Year

Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients.

World journal of gastroenterology, 2008, Dec-21, Volume: 14, Issue:47

Topics: Adult; Aged; Aged, 80 and over; Arginine; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; Portasystemic Shunt, Transjugular Intrahepatic

2008